Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.

Mayer EL, Collin SM, Hillman S, Berrocal-Almanza LC, Sparano J, Lam C.

Open source

DOI
10.1007/s10549-026-08029-w
Published
2026-07-20
Container
Breast Cancer Res Treat
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-026-08029-w,
  title = {Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.},
  author = {Mayer EL and  Collin SM and  Hillman S and  Berrocal-Almanza LC and  Sparano J and  Lam C.},
  year = {2026},
  journal = {Breast Cancer Res Treat},
  doi = {10.1007/s10549-026-08029-w},
  url = {https://doi.org/10.1007/s10549-026-08029-w}
}

RIS

TY  - JOUR
TI  - Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.
AU  - Mayer EL
AU  -  Collin SM
AU  -  Hillman S
AU  -  Berrocal-Almanza LC
AU  -  Sparano J
AU  -  Lam C.
PY  - 2026
JO  - Breast Cancer Res Treat
DO  - 10.1007/s10549-026-08029-w
UR  - https://doi.org/10.1007/s10549-026-08029-w
ER  - 

APA

EL, M., SM, C., S, H., LC, B., J, S., & C., L. (2026). Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-026-08029-w

Source records